|Articles|September 7, 2013

Compliance by Design and Compliance Master Plans

Video with Paul Pluta

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Sad blue-grey eyes of elderly woman looking to the side, extreme close-up shot | Image credit: © pressmaster - © pressmaster - stock.adobe.com

EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy

ByFeliza Mirasol

January 19th 2026

FDA headquarters at White Oak Campus in Silver Spring, Maryland, USA - January 13, 2020. The United States Food and Drug Administration (FDA) is a federal agency. | Image credit: © JHVEPhoto - © JHVEPhoto - stock.adobe.com

How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals

ByFeliza Mirasol

January 14th 2026

Closed up image of a doctor holding a glass syringe with several other syringes prefilled with blue liquid on a rack. Covid-19 vaccination concepts. | Image credit: © SOPONE - © SOPONE - stock.adobe.com

GSK Advances Vaccine Delivery and Hepatitis B Treatment

ByFeliza Mirasol

January 8th 2026

Development and creation of coronavirus vaccine COVID-19 .Coronavirus Vaccine concept in hand of doctor blue vaccine jar. Vaccine Concept of fight against coronavirus. | Image credit: © Looker_Studio - © Looker_Studio - stock.adobe.com

CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics

ByFeliza Mirasol

January 6th 2026

Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service | Image credit: © Chinnapong - © Chinnapong - stock.adobe.com

China Approves First Monthly Biologic for COPD

ByFeliza Mirasol

January 5th 2026

Compliance by Design and Compliance Master Plans

Newsletter

Related Content

EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy

How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals

GSK Advances Vaccine Delivery and Hepatitis B Treatment

CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics

China Approves First Monthly Biologic for COPD

Trending on BioPharm International

Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences

Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development

How Biopharma Navigates the 2026 Economic Shift

EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy

Novartis Calls for Global Governments to Address Global Trade Policy